Did the Trump administration refuse the COVID-19 from the WHO

[TexasBushwhacker]

because they wanted to develop an American test that they could monetize? Seriously, there is NO EXCUSE to not use the WHO test while we are developing our own. People who need it aren't getting tested.

[applegrove]

1. I've wondered that too. We don't have the information yet. I doubt the

health authorities who know have the apetite for a scandal in the middle of a pandemic so i'll go with them and not speculate.

[Ms. Toad]

2. apparently.

The federal agency shunned the World Health Organization test guidelines used by other countries and set out to create a more complicated test of its own that could identify a range of similar viruses.

https://www.propublica.org/article/cdc-coronavirus-covid-19-test

[Doodley]

3. Thousands of people may die in the meantime. Small price to help make some more dirty money.

[TexasBushwhacker]

4. Exactly

People who need it are not getting tested. People are getting quarantined unneccessarily and others that should be quarantined or treated aren't. It makes no sense!

[procon]

5. Trump was talking about the need for investors

early on. I recall reading something about the retail price for tests needed to be high enough to attract investors who looking to make a profit. That was why he ditched WHO and tried to use the CDC to develop a propriety test.

[stillcool]

6. there is this...probably nothing...but

posted the other day by RealityChil
https://www.democraticunderground.com/100213060533

Trump may be profiting from new Covid-19 test kit maker, Thermo Fisher Scientific Corp...
Amee Vanderpool
****************************
Applied Biosystems is one of the various brands under the Life Technologies brand of Thermo Fisher Scientific corporation. The brand is focused on integrated systems for genetic analysis, which include computerized machines and the consumables used within them, such as reagents.
It is safe to say that the need of the federal government to use these devices provided by the Thermo Fisher Scientific Corp. will substantially increase profitability and likely increase the value of stock in the company.
According to the Associated Press, Donald Trump, the current President of the United States who is supposed to be managing the Coronavirus epidemic and how the testing is conducted, has listed investments in V.F. Corp (VFC) and Thermo Fisher Scientific Corporation (TMO), both of which moved jobs out of the U.S. in high profile outsourcing deals. There is reason to believe that Donald Trump stands to profit from medical testing of coronavirus that will now take place in the United States.
****************************
Both Fortune Magazine and The New York Post confirmed in May of 2016 that Trump listed investments in V.F. Corp. and Thermo Fisher Scientific.https://fortune.com/2016/05/19/donald-trump-investments/ If Trump still maintains these investments, it is a direct conflict of interest to use a company that he stands to profit from to conduct coronavirus testing.
Additionally, Trump’s transition team announced in Dec. 2016, that Trump had sold all of his stock interests ahead of taking the oath of office, but there was never any proof provided to confirm this statement. When asked on a conference call with reporters whether Trump had investments in Boeing at the time, then spokesman Jason Miller said the president-elect had sold all of his stocks in June of 2016
https://shero.substack.com/p/trump-could-profit-from-coronavirus

Thermo Fisher buying Qiagen in deal worth about $10.1B
By The Associated Press Mar 3, 2020 0

The combined company will work on speeding up the development of higher-specificity, faster and more comprehensive tests that may improve patient outcomes and reduce the cost of care.

The transaction also includes approximately $1.4 billion in debt.
The deal is expected to close in the first half of 2021.
Qiagen's stock surged 16%, while shares of Thermo Fisher rose nearly 5% in Tuesday premarket trading.

https://www.heraldextra.com/business/thermo-fisher-buying-qiagen-in-deal-worth-about-b/article_5d6a9f5b-64b8-5996-871f-aa4aff77e617.html

THere are the corporate dealmakers joining Trump in China
Published Thu, Nov 2 20171:44 PM EDT
https://www.cnbc.com/2017/11/02/here-are-the-corporate-dealmakers-joining-trump-in-china.html
Kayla Tausche
@kaylatausche
When President Trump lands in China next week, he’ll be joined by more than two dozen business titans.
A state banquet will be held in honor of Trump’s visit.
Among the attendees are Goldman Sachs CEO Lloyd Blankfein, Qualcomm CEO Steve Mollenkopf, Cheniere Energy CEO Jack Fusco and Air Products CEO Seifollah Ghasemi.
Companies may announce multibillion-dollar export deals.

At the bottom there is this list of attendees, and pretty far down is:

This is the list of attendees:
Gianluca Pettiti, president, Thermo Fisher Scientific China